Related Experiment Video

Updated: Jun 12, 2026

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

[Relationship between sleep duration and metabolic syndrome in obese children]

Fang Zhou1, Jun-fen Fu, Chun-lin Wang

  • 1Department of Endocrinology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou 310003, China.

Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|June 2, 2010
PubMed

Insights

Obese children with insufficient sleep, less than 8 hours daily, show higher risks for metabolic syndrome (MS). This study highlights that reduced sleep duration is a significant risk factor for MS development in this population.

Area of Science:

  • Pediatrics
  • Metabolic Health
  • Sleep Science

Background:

  • Metabolic syndrome (MS) is a growing concern in obese children.
  • Understanding contributing factors to MS in pediatric obesity is crucial for effective interventions.

Purpose of the Study:

  • To examine the association between sleep duration and the prevalence of metabolic syndrome in obese children.
  • To identify sleep duration as a potential risk factor for metabolic syndrome in pediatric obesity.

Main Methods:

  • A study involving 311 obese children measured sleep duration and key metabolic syndrome criteria, including blood pressure and body mass index (BMI).
  • Participants were categorized into four sleep duration groups, with normal-weight children serving as controls.
  • Logistic regression analysis was employed to assess the relationship between sleep duration and MS.

Main Results:

  • Children sleeping less than 8 hours daily exhibited significantly higher BMI, blood pressure, fasting blood glucose, and postprandial glucose levels compared to those sleeping 10 hours or more.
  • The incidence of abnormal metabolic syndrome indicators, including elevated blood pressure and BMI over 30 kg/m², was significantly higher in the shorter sleep duration group.
  • Logistic regression confirmed that reduced sleep duration is a significant risk factor for metabolic syndrome in obese children.

Conclusions:

  • Insufficient sleep duration is strongly linked to an increased risk of developing metabolic syndrome in obese children.
  • Promoting adequate sleep may be a vital strategy in managing and preventing metabolic syndrome in pediatric obesity.
Abstract

More Related Videos

Assessment of Child Anthropometry in a Large Epidemiologic Study09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings06:39

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings

Published on: June 13, 2025

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...